One-year outcome after preconception consultation in women with bipolar disorder

Journal of Clinical Psychiatry

Volumn 71, Issue 6, 2010, Pages 806-

  Wieck, Angelika ^a,b   Kopparthi, Sreevalli ^a   Sundaresh, Sushma ^c   Wittkowski, Anja ^a,b  

^a GREATER MANCHESTER MENTAL HEALTH NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c South Kensington and Chelsea Mental Health Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; AFFECTIVE NEUROSIS; ANTICONVULSANT THERAPY; BIPOLAR DISORDER; DISEASE SEVERITY; FEMALE; HOSPITALIZATION; HUMAN; HYPERPROLACTINEMIA; HYPOMANIA; LETTER; MAJOR CLINICAL STUDY; MATERNAL CARE; PREGNANCY; PRIORITY JOURNAL; TERATOGENICITY; UNITED KINGDOM;

ADULT; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; PATIENT CARE MANAGEMENT; PATIENT CARE PLANNING; PRECONCEPTION CARE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PSYCHIATRY; PSYCHOTROPIC DRUGS; REFERRAL AND CONSULTATION; TREATMENT OUTCOME;

EID: 77953764575     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.09l05596yel     Document Type: Letter

References (7)

1. Freeman MP. Perinatal psychiatry: risk factors, treatment data, and specific challenges for clinical researchers. J Clin Psychiatry. 2008;69(4):633-634.
2. Viguera AC, Whitfield T, Baldessarini RJ, et al. Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatry. 2007;164(12):1817-1824, quiz 1923. (Pubitemid 351739234)
3. Viguera AC, Nonacs R, Cohen LS, et al. Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am J Psychiatry. 2000;157(2):179-184. (Pubitemid 30080895)
4. Meador K, Reynolds MW, Crean S, et al. Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts. Epilepsy Res. 2008;81(1):1-13.
5. Matalon S, Schechtman S, Goldzweig G, et al. The teratogenic effect of carbamazepine: a meta-analysis of 1255 exposures. Reprod Toxicol. 2002;16(1):9-17. (Pubitemid 34308448)
6. Wieck A. Teratogenic syndromes. In: Haddad PM, Dursun S, Deakin B, eds. Adverse Syndromes and Psychiatric Drugs. London, England: Oxford University Press; 2004:161-181.
7. Holmes LB, Baldwin EJ, Smith CR, et al. Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy. Neurology. 2008;70(22 pt 2):2152-2158.